Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05294445 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

From the Emergency Department Directly to Ablation of Atrial Fibrillation Study

Study acronym: EMERGE-Cryo
StatusActive, Not Recruiting
PhaseNot applicable
Started2021-12-15
View on ClinicalTrials.gov ↗

Amendment history

2026-05-20
Study Status, Eligibility v4
Re-verified, no change to tracked fields
2026-04-28
Recruiting→Active, Not Recruiting Study Identification, Study Status, Oversight, Study Design, Contacts/Locations, References v3
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 13 of 13 sites
Publicationsdetails revised at 21 of 22 entries
2025-04-08
Study Identification, Study Status, Contacts/Locations v2
Study sites12→13
2025-02-26
Study Identification, Study Status, Oversight, Eligibility, Contacts/Locations, References v1
Completion date2027-12-14→2028-12-14
Study sites1→12
Eligibility criteria+48 characters
[...] nfection Co-Existence of non PV-dependent atrial Tachycardia Indication for implantation of ICD or pacemaker
Publicationsdetails revised at 21 of 22 entries
2022-03-23
Original filing
The study is a prospective, two-arm, randomized, open-label, blinded endpoint, multi-center study to investigate the impact of first line ablation in patients presenting at the emergency room with recent-onset paroxysmal or persistent atrial fibrillation.
Trial Details
NCT Number NCT05294445
Lead Sponsor Asklepios proresearch
Collaborators: Atrial Fibrillation Network, Medtronic Bakken Research
Conditions Atrial Fibrillation (AF)
Enrollment 350 participants
Start Date 2021-12-15
Primary Completion 2026-12-14 (estimated)
Study Completion 2028-12-14 (estimated)
Updated on ClinicalTrials.gov 2026-05-22